The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Category

Sub-category

Conference

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal c...

Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA

Safety of sotorasib and panitumumab in advanced KRAS p.G12C-mutated colorectal cancer ( Dr Marwan Fakih - City of Hope Comprehensive Cancer Center, Duarte, USA )

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with ...

Dr Jared Weiss - UNC School of Medicine, Chapel Hill, USA

KRYSTAL-1: Adagrasib as monotherapy or combined with cetuximab in patients with CRC harboring a KRASG12C mutation ( Dr Jared Weiss - UNC School of Medicine, Chapel Hill, USA )

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) w...

Dr Pei-Rong Ding - Sun Yat-sen University Cancer Center, Guangzhou, China

Neoadjuvant chemotherapy with CapeOx alone vs standard chemoradiotherapy (CRT) with Capecitabine for patients with LARC ( Dr Pei-Rong Ding - Sun Yat-sen University Cancer Center, Guangzhou, China )

OncoAlert and ecancer - ESMO 2021 Day 4

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer - ESMO 2021 Day 4 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-l...

Dr Chiara Cremolini - University of Pisa, Pisa, Italy

FOLFOXIRI + bevacizumab + atezolizumab versus FOLFOXIRI + bevacizumab as first-line treatment of unresectable mCRC patients ( Dr Chiara Cremolini - University of Pisa, Pisa, Italy )

ESMO President: What to watch for at ESMO 2021

Prof Solange Peters - ESMO President

ESMO President: What to watch for at ESMO 2021 ( Prof Solange Peters - ESMO President )

Oesophageal and gastric cancers

Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA

Oesophageal and gastric cancers ( Dr Mike Cusnir - Mount Sinai Medical Center, Florida, USA )

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment

Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel

BEACON-CRC: first-line bevacizumab in colorectal cancer treatment ( Prof Dan Aderka - Tel-Aviv University, Tel-Aviv, Israel )

OncoAlert and ecancer weekly round up for July 12- July 18, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 12- July 18, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600...

Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain

$Cell free DNA BRAF mutant allele fraction and whole exome sequencing in BRAFV600E metastatic colorectal cancer ( Dr Elena Elez - Vall d'Hebron University Hospital, Barcelona, Spain )$

OncoAlert and ecancer weekly round up for July 1- July 10, 2021

Dr Gil Morgan - Skåne University Hospital in Lund, Sweden

OncoAlert and ecancer weekly round up for July 1- July 10, 2021 ( Dr Gil Morgan - Skåne University Hospital in Lund, Sweden )

Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in...

Dr Zev Wainberg - University of California Los Angeles, California, USA

Study of the anti-TIGIT antibody tiragolumab in combination with atezolizumab in patients with metastatic oesophageal cancer ( Dr Zev Wainberg - University of California Los Angeles, California, USA )

More from ecancer